Skip to content

Management of Allergic Rhinitis by Homoeopathic Medicines

Single Blind Randomized Study to Evaluate Efficacy of Solanium Lycopersicum in Comparison with Individualized Homoeopathic Medicines in Cases of Allergic Rhinitis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059458
Enrollment
120
Registered
2023-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Selection of Homoeopathic Medicine will be based on individualization, after proper analysis, evaluation and miasmatic analysis of the case as per homoeopathic principles: Selection of
dosage and repetition depending upon the individual requirement of the cases. Duration of therapy: 06 months with follow up at every 15 days.

Sponsors

Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: >Newly diagnosed and pre-diagnosed cases of Allergic Rhinitis. >Diagnosed cases of Allergic Rhinitis who have taken medicines from any other system of treatment like Allopathy, Ayurvedic, etc. will also be considered after a washout period of 15 days. >Patients who have previously taken Homoeopathy medicines prior to the visit were also taken into consideration after 1 month of washout period. >The patients who have given their consent to participate in study with follow ups.

Exclusion criteria

Exclusion criteria: >The cases which did not fulfil the inclusion criteria. >Patient having Allergic Rhinitis in association with other autoimmune disorders. >Patients with other respiratory diseases and other systemic illness (Diabetes Mellitus, Metabolic Syndrome, Cardiovascular diseases, Endometrial neoplasia) etc. Rhinitis secondary to anatomical abnormalities or any other complications. >Pregnant women and lactating mothers. >Patients not giving written consent. >Cases with irregular follow up.

Design outcomes

Primary

MeasureTime frame
improvement of symptoms with decreased frequency of Allergic RhinitisTimepoint: 6 months

Secondary

MeasureTime frame
Improvement in the quality of lifeTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Krishnaben Raj

Parul University

jnhmc@paruluniversity.ac.in9376225507

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026